4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-011771
General Counsel sold 8,869 shares at $0.67 ($5,942)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-05 | Sale : show line 1 in the form | −8,869 | $0.67 | $5,942 | 225,363 | D |
| Open-market sales · 8,869 sh · avg $0.67 · $5,942 | ||||||
Loading xslF345X05/ownership.xml…